Gilead Gets European Commission Marketing Authorization For HIV-1 Infection Drug

By: via Benzinga
Gilead Sciences, Inc. (NASDAQ: GILD) revealed that the European Commission has given its marketing authorization for two doses of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.